Skip to content
Diabetes Update 2022: Program Evaluation - Friday, April 29th
Your feedback provides us with vital information that assists in the development of future educational initiatives.
Assessment of Learning Objectives
Using a scale of poor to excellent, please indicate your level of confidence in the learning objective as it relates to your knowledge, belief, or behavior, pre-program and post-program.
Diabetes and Heart Failure: What must a diabetologist know? | Shelley Zieroth, MD
Your knowledge of screening, diagnosis and management of heart failure in patients with diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of the new therapeutics (including SGLT2i) in the prevention and treatment of heart failure in patients with diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Obesity and Diabetes | Sean Wharton, MD
Your knowledge of
non-pharmacologic
and pharmacologic management of obesity in patients with diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of recommendations pertaining to bariatric surgery in patients with diabetes and obesity:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Decolonizing Diabetes Health Care | Randal Bell
Your knowledge of the prevalence of diabetes in Indigenous communities:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of the current systemic barriers to Indigenous health and diabetes management:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of strategies and initiatives to reduce the burden of diabetes in Indigenous people:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Update on Incretin Therapies | Alice Cheng, MD
Your knowledge of the evolution of the role of incretin therapies in the contemporary management of diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of the therapeutic potential and future applications of triple agonist therapy:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Nutrition and Diabetes | Michael Mindrum, MD
Your knowledge of current and evolving nutritional approaches for the prevention and management of diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Diabetes and Mental Health | Barry Simon, MD
Your knowledge of approaches for the screening and diagnosis of binge eating disorder and depression in patients with diabetes including specific screening tools:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of treatment interventions, both lifestyle and pharmacologic, for depression and binge eating disorder:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Diabetes and Chronic Kidney Disease | David Cherney, MDCM
Your knowledge of updates in recent evidence for therapies for diabetic kidney disease:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Your knowledge of current recommended management strategies for patients with diabetes and chronic kidney disease:
Poor
Fair
Good
Very Good
Excellent
Before
Poor
Fair
Good
Very Good
Excellent
After
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Additional Feedback
2. From what you have learned, how will this impact / modify your practice and what will you be able to apply to your practice? What potential barriers do you anticipate and how will you overcome them?
Impact on my practice and key learnings that I will apply:
Potential barriers and solutions to overcome them:
Please indicate which CanMEDS roles you felt were addressed during this educational activity?
Medical Expert
Scholar
Collaborator
Communicator
Manager
Professional
Health Advocate
Sessions allocated at least 25% of the time for interaction
Yes
No
Comments:
Did you perceive any sources of commercial bias in any of the sessions? If so, please explain:
Yes
No
Comments:
Did the activity comply with the Code of Ethics for parties involved in continuing medical education?
Yes
No
Comments:
Were there any topics you think should have been addressed? Any recommendations for future sessions?
Please share any additional comments:
Thank you!